Dr Abonour is Professor of Medicine and Professor of Pathology and Laboratory Medicine at the Indiana University School of Medicine and a physician/researcher at the Indiana University Melvin and Bren Simon Cancer Center in Indianapolis. He also is the director of the Multiple Myeloma Program and related plasma cell disorders and associate dean for clinical research. After receiving his medical degrees from the University of Damascus Syria, he trained in internal medicine, immunology, hematology and bone marrow transplantation at the University of Wisconsin-Madison. Dr Abonour's research efforts focus on finding novel agents and combination therapies to better manage patients with multiple myeloma. He is active in many national and international cooperative groups, and he serves on several key committees that help shape the practice of hematology. Dr Abonour's work has been published in Nature Medicine and the New England Journal of Medicine among others.

Dr. Camacho has over 25 years' experience as a Medical Oncologist and Hematologist. In 2006, 2007, 2008 and 2009, he was recognized by his peers as being among the area's Top Doctors from survey results published by Palm Springs Life magazine. He was recruited to the Comprehensive Cancer Center in 1995 from Loma Linda (CA) University, where he earned his medical degree and was on the teaching staff. Dr. Camacho also was a fellow in Hematology and Immunology at Memorial Sloan-Kettering Hospital in New York. He is board certified in Internal Medicine, Medical Oncology and Hematology. He specializes in general hematology and malignant hematology with emphasis on leukemia, lymphoma and multiple myeloma. In addition to his duties as Medical Director of the Comprehensive Cancer Center, Dr. Camacho serves as Medical Director of the Hospice Program at Desert Regional Medical Center.

Adam D. Cohen, MD is an Assistant Attending Physician and Associate Member at Fox Chase Cancer Center in Philadelphia, Pennsylvania, where his research focuses on multiple myeloma and amyloidosis. Dr. Cohen obtained his medical degree and internal medicine residency training from the University of Pennsylvania. He then completed a fellowship in hematology/oncology at Memorial Sloan-Kettering Cancer Center in New York, NY, where he was also a Research Associate in the Laboratory of Tumor Immunology.

Dr. Cohen is a member of various medical and scientific societies including the American College of Physicians, the American Society of Clinical Oncology, the American Association for Cancer Research, the American Society for Blood and Marrow Transplantation, and the American Society of Hematology. He is also a member of the NCCN Multiple Myeloma Panel.

Dr. Cohen is a reviewer for Annals of Oncology, Cytotherapy, the Journal of Translational Medicine, Blood, Amyloid, and Clinical Cancer Research. He is an author on over 30 scientific publications, book chapters, and reviews.

Dr. Stadtmauer is Director of the Hematologic Malignancies and Bone Marrow and Stem Cell Transplant Program at the Abramson Cancer Center of the University of Pennsylvania in Philadelphia, PA. He has been associated with the university for 23 years. He was the Co-Chairman of the Bone Marrow Transplant Committee of the Eastern Cooperative Oncology Group (ECOG) for ten years and is a member of the Myeloma and Leukemia Core Committees. He is also a member of the Steering Committee of the NIH sponsored Blood and Marrow Transplant Clinical Trial Network and a founding member of the Aptium Myeloma Consortium.

Dr. Stadtmauer is widely published on the subjects of multiple myeloma, acute and chronic leukemia, and autologous bone marrow transplantation. He has been appointed to the editorial boards of the Journal of Clinical Oncology and Bone Marrow Transplantation. His works have appeared in such premier peer-reviewed journals as the New England Journal of Medicine, Journal of Clinical Oncology, British Journal of Haematology, Blood, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation, Nature Medicine and Annals of Internal Medicine.

Dr. Stadtmauer graduated with a degree with distinction in biochemistry from Cornell University and then completed his MD at the University of Pennsylvania School of Medicine. He served his internship and residency in internal medicine at the Albert Einstein College of Medicine in the Bronx, NY. He earned his Fellowship in Hematology/Oncology at the University of Pennsylvania where he founded the Bone Marrow Transplant Program in 1987 and the Myeloma Program in 1999.